Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JGN2 | ISIN: SE0010869552 | Ticker-Symbol: 5J2
Frankfurt
01.11.24
11:08 Uhr
0,035 Euro
-0,006
-15,53 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
GABATHER AB Chart 1 Jahr
5-Tage-Chart
GABATHER AB 5-Tage-Chart

Aktuelle News zur GABATHER Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.09.Nasdaq Stockholm AB: New equity right for trading, Gabather TO 6209At the request of Gabather AB, equity rights TO 6 will be traded on First North Growth Market as from 5 September 2024. Security name: Gabather TO 6 ----------------------------- Short name: GABA...
► Artikel lesen
19.07.XFRA CAPITAL ADJUSTMENT INFORMATION - 19.07.2024356Das Instrument D7GA US64026Q1085 NEL ASA ADR/30 NK -,20 EQUITY wird cum Kapitalmassnahme gehandelt am 19.07.2024 und ex Kapitalmassnahme am 22.07.2024 The instrument D7GA US64026Q1085 NEL ASA ADR/30...
► Artikel lesen
10.04.Gabather AB: Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002302STOCKHOLM, April 10, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for Neuropsychiatric...
► Artikel lesen
18.03.Gabather AB: Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders278STOCKHOLM, March 18, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional patent applications based on novel findings from the...
► Artikel lesen
07.03.Gabather AB: Gabather reports initial positive results from the EEG/fMRI target engagement study260STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded...
► Artikel lesen
15.01.Nasdaq Stockholm AB: New equity right for trading, Gabather TO 5 (24/24)445At the request of Gabather AB, equity rights TO 5 will be traded on First North as from 16 January 2024. Security name: Gabather TO 5 ----------------------------- Short name: GABA TO 5 ----------------------------- ISIN...
► Artikel lesen
09.01.Nasdaq Stockholm AB: Last day of trading in paid subscription units (BTU) of Gabather AB (publ) (12/24)351Trading in Gabather AB paid subscription units is to cease. The last trading day is January 10, 2024. Short name: GABA BTU ISIN code: SE0021149721 Orderbook ID: 313990 This information is distributed...
► Artikel lesen
05.12.23Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Gabather AB (633/23)487With effect from December 06, 2023, the unit rights in Gabather AB will be traded on First North Growth Market. Trading will continue up until and including December 15, 2023. Instrument: Unit rights...
► Artikel lesen
28.11.23Nasdaq Stockholm AB: Gabather AB receives observation status (606/23)440Yesterday, on November 27, 2023, Gabather AB (the "Company") disclosed its interim report for the third quarter of 2023 with information on the Company's financial situation. The rules of Nasdaq First...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1